Tag: Ogier
Deals of the year 2022
China Business Law Journal announces the most exciting China-related legal transactions and disputes of 2022
China’s YishengBio eyes US capital markets via SPAC route
Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023
Global IP specialist Peat joins Ogier
Ogier has strengthened its IP prowess with the hire of global IP expert Sophie Peat as partner
China Business Law Awards 2022
China Business Law Journal reveals the law firms that have excelled in the past year
LATEST ON VANTAGE ASIA
Knowing is half the battle
Sadaff Habib, an independent arbitrator based in Dubai, points out the major challenges in local arbitration and offers key tips for Chinese businesses
